CME Webinar: Advances in the Treatment of COPD

Objectives

After participating in this activity, the learner will demonstrate the ability to:

• Explain the impact that COPD has on the population of the US and the impact of COVID-19 on patients with COPD
• Discuss new guidelines available for the treatment of COPD
• Describe discrepancies between guidelines and practice and discuss how these can be overcome

Accreditation Statement

Policy On Presenter And Provider Disclosure

It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the presentation of the education.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with ineligible companies from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Dr. Meilan Han has a current financial relationship with National Institute of Health, Sanofi-Aventis, Novartis AG, Sunovion, Gala Therapeutics, COPD Foundation, AstraZeneca, American Lung Association, Boehringer Ingelheim, Biodesix, Uptodate, Norton Publishing, Penguin Random House, GlaxoSmithKline, Pulmonx, Teva Pharmaceuticals, Verona, Merck and Company, Mylan, DevPro, Aerogen, Polarian, United Therapeutics, Regeneron, Altesa BioPharma, Cipla, Chiesi, Medscape, Integrity, NACE, COPD Foundation Scientific Advisory Committee, ALA Advisory Committee, American Thoracic Society, ALA, GOLD Scientific Committee, Emerson School Board, Meissa Vaccines, .

Dr. Fernando Martinez has a current financial relationship with AstraZeneca, Chiesi, GlaxoSmithKline, Novartis, Sanofi-Aventis, Regeneron, and Medtronic.

Note: Grants to investigators at Johns Hopkins University are negotiated and administered by the institution that receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor but may receive salary or other support from the institution to support their effort on the project(s).

Johns Hopkins Statement Of Responsibility

The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Copyright

All rights reserved – The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

ACKNOWLEDGEMENTS

We wish to acknowledge the following companies that have provided an educational grant in support of this activity: Viatris Pharmaceuticals, Glaxo Smith Kline, and Chiesi USA.

Internet CME Policy

The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its internet site as an information resource and service for physicians, other health professionals, and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request. 

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own.  This enduring material is produced for educational purposes only.  The use of Johns Hopkins School of Medicine name implies a review of the educational format design and approach.  Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Americans With Disabilities Act

The Johns Hopkins School of Medicine (and the Institute for Johns Hopkins Nursing) fully complies/comply with the legal requirements of the ADA and the rules and regulations thereof.  Please notify us if you have any special needs.

RELEASE DATE
02/21/2023

EXPIRATION DATE
04/21/2024

Course Format – Method Of Participation

This live material is expected to take approximately 1.5 hours to complete. Once the activity is completed, participants must pass the post-test and complete the evaluation with attestation to receive CME credit.

Post-Test

A post-test will be conducted at the conclusion of the activity. No minimum grade is needed to receive CME credit.

Faculty

Ashraf Fawzy, MD, MPH
Assistant Professor of Medicine
Johns Hopkins University
Baltimore, Maryland

Melian King Han, MD, MS
Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan
Ann Arbor, Michigan

Fernando Martinez, MD, MS
Chief of the Pulmonary and Critical Care Medicine Division
Weill Cornell Medicine
New York, New York

Confidentiality Disclaimer for CME Activity Participant

I certify that I am participating in this Johns Hopkins School of Medicine activity for CME-accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person’s health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g., Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is:  Johns Hopkins Privacy Officer, telephone: 410-614-9900, e-mail: [email protected].

“The Office of Continuing Medical Education at the Johns Hopkins School of Medicine, as sponsor of this activity, has relayed information with the CME attendees/participants and certify that the visitor is here for training, education and/or observation purposes only.”

For CME questions, please contact the CME Office 410-955-2959 or email[email protected].

For CME Certificates, please call (410) 502-9636.

Johns Hopkins School of Medicine
Office of Continuing Medical Education
720 Rutland Avenue/ Turner 20
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Click the ‘START ACTIVITY’ button above to begin. You will be asked to create a free account or to sign into your account if you already have one.

Complete a brief pre-assessment and then view the webinar (approximately 90 minutes). After viewing the entirety of the webinar, you must click ‘NEXT’ and complete the post- assessment to receive credit. A grade of at least 70% within three attempts is needed to receive CME credit.